European Medicines Agency (EMA)
EMA/76828/2018
Women taking Esmya for uterine fibroids to have regular liver tests while EMA review is ongoing.
No new patients should start treatment for the time being
Télécharger l'article (en Anglais)
Lien source :
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/02/news_detail_002902.jsp&mid=WC0b01ac058004d5c1
